Rapid Assay for the Therapeutic Drug Monitoring of Edoxaban

Edoxaban is a direct oral anticoagulant (DOAC) that has been recently indicated for the treatment of pulmonary embolism (PE) in SARS-CoV-2 infections. Due to its pharmacokinetic variability and a narrow therapeutic index, the safe administration of the drug requires its therapeutic drug monitoring (...

Descripción completa

Detalles Bibliográficos
Autores principales: Rashid, Md Abdur, Muneer, Saiqa, Alhamhoom, Yahya, Islam, Nazrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027065/
https://www.ncbi.nlm.nih.gov/pubmed/35454179
http://dx.doi.org/10.3390/biom12040590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027065/
https://www.ncbi.nlm.nih.gov/pubmed/35454179
http://dx.doi.org/10.3390/biom12040590

Ejemplares similares